Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TVTX Travere Therapeutic > Detailed Quotes

TVTX Travere Therapeutic

26.070
-0.070-0.27%
Close 10/06 16:00 ET
26.0700.0000.00%
Post Mkt Price 10/06 16:29 ET
High
26.550
Open
25.990
Turnover
9.63M
Low
25.915
Pre Close
26.140
Volume
367.97K
Market Cap
1.67B
P/E(TTM)
Loss
52wk High
31.650
Shares
63.96M
P/E(Static)
Loss
52wk Low
20.800
Float Cap
1.21B
Bid/Ask %
-33.33%
Historical High
37.040
Shs Float
46.22M
Volume Ratio
0.46
Historical Low
0.000
Dividend TTM
--
Div Yield TTM
--
P/B
10.64
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.80%
Amplitude
2.43%
Avg Price
26.176
Lot Size
1
Float Cap
1.21B
Bid/Ask %
-33.33%
Historical High
37.040
Shs Float
46.22M
Volume Ratio
0.46
Historical Low
0.000
Dividend TTM
--
P/B
10.64
Dividend LFY
--
Turnover Ratio
0.80%
Amplitude
2.43%
Avg Price
26.176
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
CEO: Dr. Eric Dube, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...